Machtay Mitchell, Scherpereel Arnaud, Santiago José, Lee James, McDonough Jim, Kinniry Paul, Arguiri Evguenia, Shuvaev Vladimir V, Sun Jing, Cengel Keith, Solomides Charalambos C, Christofidou-Solomidou Melpo
Department of Medicine, Pulmonary, Allergy, and Critical Care Division, Thomas Jefferson University Medical Center, Philadelphia, PA 19104, USA.
Radiother Oncol. 2006 Nov;81(2):196-205. doi: 10.1016/j.radonc.2006.09.013. Epub 2006 Oct 27.
Since oxidative injury is implicated in radiation-induced tissue damage to the lung, we studied systemically administered polyethylene glycol (PEGylated) antioxidant enzymes (AOEs) as pulmonary radioprotectors in mice.
C57/bl6 Mice received 13.5 Gy single-dose irradiation to the thorax. One cohort also received 100 microg of a 1:1 mixture of PEG-AOEs {PEG-catalase and PEG-superoxide dismutase (SOD)} intravenously, pre-irradiation and subgroups were evaluated at variable time-points for inflammation and fibrosis. Potential for AOE tumor protection was studied by thoracic irradiation of mice with Lewis lung carcinoma.
At 48 h post-irradiation, control irradiated mice had marked elevations of tissue p21, Bax and TGF-beta1 in lungs, not seen in irradiated, PEG-AOE-treated mice. TUNEL staining of lung sections was performed at just one time-point (24 h post-irradiation) and revealed a decrease in apoptotic cells with AOE treatment. At four months post-irradiation, these mice had significantly increased pulmonary fibrosis as measured by hydroxyproline content. Mice treated with PEG-AOE prior to irradiation had 4-month hydroxyproline levels that were similar to that of unirradiated controls (p = 0.28). This corresponded to less pulmonary fibrosis as visualized histologically when compared with mice irradiated without AOEs. PEG-AOEs did not prevent post-irradiation pulmonary inflammation or lung cancer response to irradiation.
A mixture of PEG-SOD and PEG-CAT successfully diminished radiation pulmonary fibrosis in mice. There was also a corresponding effect on several early biomarkers of lung injury and decreased apoptosis. There were no significant effects on acute pneumonitis or tumor protection.
由于氧化损伤与辐射诱导的肺部组织损伤有关,我们系统地研究了静脉注射聚乙二醇(PEG化)抗氧化酶(AOE)作为小鼠肺部辐射防护剂的作用。
C57/bl6小鼠接受13.5 Gy单次胸部照射。一组在照射前还静脉注射100微克PEG - AOE(PEG - 过氧化氢酶和PEG - 超氧化物歧化酶(SOD))1:1混合物,并在不同时间点评估亚组的炎症和纤维化情况。通过对患有Lewis肺癌的小鼠进行胸部照射来研究AOE对肿瘤的保护潜力。
照射后48小时,对照照射小鼠肺部组织中的p21、Bax和TGF - β1显著升高,而在接受PEG - AOE治疗的照射小鼠中未观察到这种情况。仅在一个时间点(照射后24小时)对肺切片进行TUNEL染色,结果显示AOE治疗可使凋亡细胞减少。照射后四个月,通过羟脯氨酸含量测定,这些小鼠的肺纤维化显著增加。照射前用PEG - AOE治疗的小鼠四个月时的羟脯氨酸水平与未照射对照相似(p = 0.28)。与未接受AOE照射的小鼠相比,组织学观察显示这对应于较少的肺纤维化。PEG - AOE不能预防照射后肺部炎症或肺癌对辐射的反应。
PEG - SOD和PEG - CAT混合物成功减轻了小鼠的放射性肺纤维化。对肺损伤的几种早期生物标志物也有相应影响,并减少了细胞凋亡。对急性肺炎或肿瘤保护没有显著影响。